Macrophage colony stimulating factor: Not just for macrophages anymore! A gateway into complex biologies

International Immunopharmacology

Volumn 8, Issue 10, 2008, Pages 1354-1376

  Douglass, Thomas G ^a   Driggers, Lara ^b   Zhang, Jian Gang ^b,c   Hoa, Neil ^b   Delgado, Christina ^b   Williams, Christopher C ^b   Dan, Qinhong ^b   Sanchez, Ramon ^b   Jeffes, Edward W B ^b   Wepsic, H Terry ^b   Myers, Michael P ^a   Koths, Kirston ^d   Jadus, Martin R ^b,c,e  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of California Irvine ^*  (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokine; Macrophage colony stimulating factor; Tumor

Indexed keywords

COLONY STIMULATING FACTOR 1; EPITOPE; TUMOR VACCINE;

ALTERNATIVE RNA SPLICING; ANTIANGIOGENIC ACTIVITY; BONE; CANCER IMMUNIZATION; CELL KILLING; CYTOKINE PRODUCTION; GLIOMA CELL; HUMAN; IMMUNOREGULATION; INTESTINE; METASTASIS; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN VARIANT; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; TUMOR IMMUNOLOGY; VACCINATION;

EPITOPES, T-LYMPHOCYTE; GLIOMA; HUMANS; INTESTINES; MACROPHAGE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MONOCYTES; SIGNAL TRANSDUCTION; VACCINATION;

EID: 50949094185     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.04.016     Document Type: Review

References (200)

1. Metcalf D. Hematopoietic cytokines. Blood 111 (2008) 485-491
2. Robinson W.A., Stanley E.R., and Metcalf D. Stimulation of bone marrow colony growth in vitro by human urine. Blood 33 (1969) 396-399
3. Metcalf D., and Stanley E.R. Hematological effects in mice of partially purified colony stimulating factor (CSF) prepared from human urine. Br J Haematol 21 (1971) 481-492
4. Stanley E.R., Cifone M., Heard P.M., and Defendi V. Factors regulating macrophage production and growth: identity of colony-stimulating factor and macrophage growth factor. J Exp Med 143 (1976) 631-647
5. Stanley E.R., Chen D.M., and Lin H.S. Induction of macrophage production and proliferation by a purified colony stimulating factor. Nature 274 (1978) 168-170
6. Stanley E.R. Colony stimulating factor-1. Human Cytokines 12 (1992) 196-220
7. Stanley E.R., Berg K.L., Einstein D.B., Lee P.S., Pixley F.J., Wang Y., and Yeung Y.G. Biology and action of colony-stimulating factor-1. Mol Rep Dev 46 (1997) 4-10
8. Yeung Y.G., and Stanley E.R. Proteomic approaches to the analysis of early events in colony-stimulating factor-1 signal transduction. Mol Cell Proteomics 2 (2003) 1143-1155
9. Pixley F.J., and Stanley E.R. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14 (2004) 628-638
10. Chitu V., and Stanley E.R. Colony stimulating factor-1 in immunity and inflammation vol. 18 (2006) 39-48
11. Nemunaitis J., Shannon-Dorcy K., Appelbaum F.R., Meyers J., Owens A., Day R., Ando, et al. Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood 82 (1993) 1422-1427
12. Roilides E., Lyman C.A., Mertins S.D., Cole D.J., Venzon D., Pizzo P.A., et al. Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogens. Cytokine 8 (1996) 42-48
13. Baker G.R., and Levin J. Transient thrombocytopenia produced by administration of macrophage colony stimulating factor: investigations of the mechanism. Blood 91 (1998) 89-99
14. Takashima A., Edelbaum D., Kitajima T., Shadduck R.K., Gilmore G.L., Xu S., et al. Colony-stimulating factor-1 secreted by fibroblasts promotes the growth of dendritic cell lines (XS series) derived from murine epidermis. J Immunol 154 (1995) 5128-5135
15. Ginhoux F., Tacke F., Angeli V., Bogunovic M., Loubeau M., Dai X.M., et al. Langerhans cells arise from monocytes in vivo. Nat Immunol 7 (2006) 265-273
16. Fancke B., Suter M., Hochrein H., and O'Keeffe M. M-CSF: a novel plasmacytoid and conventional dendritic cell protein. Blood 111 (2008) 150-159
17. Shadle P.J., Allen J.I., Geier M.D., and Koths K. Detection of endogenous macrophage colony-stimulating factor (M-CSF) in human blood. Exp Hematol 17 (1989) 154-159
18. Praloran V., Coupey L., Donnard M., Berrada L., and Naud M.F. Evaluation of serum M-CSF concentrations during pregnancy and ovarian hyperstimulation. Br J Haematol 86 (1994) 675-677
19. Katano K., Matsumoto Y., Ogasawara M., Aoyama T., Ozaki Y., Kajiura S., and Aoki K. Low serum M-CSF levels are associated with unexplained recurrent abortion. Am J Reprod Immunol 38 1 (1997) 1-5
20. Hayashi M., Numaguchi M., Watabe H., and Yaoi Y. High blood levels of macrophages colony-stimulating factor in pre-eclampsia. Blood 88 12 (1996) 4426-4428
21. Hayashi M., Hombo Y., Shibazaki M., Nakajima A., and Inaba N. Elevation of macrophage colony-stimulating factor in amniotic fluid at late stage of normal pregnancy. Am J Reprod Immunol 55 (2006) 226-231
22. Pollard J.W. Role of colony-stimulating factor-1 in reproduction and development. Mol Reprod Dev 46 (1997) 54-60
23. Pampfer S., Arceci R.J., and Pollard J.W. Role of colony stimulating factor-1 (CSF-1) and other lympho-hematopoietic growth factors in mouse pre-implantation development. BioEssays 13 (1991) 535-540
24. Sapi E., and Kacinski B.M. The role of CSF-1 in normal and neoplastic breast physiology. Proc Soc Exp Biol Med 220 (1999) 1-8
25. Keshava N., Gubba S., and Tekmal R.R. Over expression of macrophage colony stimulating factor (CSF-1) and it's receptor, c-fms, in normal ovarian granulose cells leads to cell proliferation and tumorigenesis. J Soc Gynecol Investig 6 (1999) 41-49
26. Mamata D., Sanford T., and Wood G. Relationship between macrophage colony-stimulating factor production by uterine epithelial cells and accumulation and distribution of macrophages in the uterus of pregnant mice. J Leukoc Biol 53 (1993) 240-248
27. Shinetugs E., Runesson E., Bonello N., Brannstrom M., and Norman R. Colony stimulating factor-1 concentrations in blood and fluid during the human menstrual cycle and ovarian stimulation: possible role in the ovulatory process. Hum Reprod 14 (1999) 1302-1306
28. Sapi E. The role of CSF-1 in normal physiology of mammary gland and breast cancer: an update. Exp Biol Med 229 (2004) 1-11
29. Bartocci A., Pollard J., and Stanley E. Regulation of colony-stimulating factor-1 during pregnancy. J Exp Med 164 (1986) 956-961
30. Pollard J.W., Bartocci A., Arceci R., Orlofsky A., Ladner M.B., and Stanley R. Apparent role of the macrophage growth factor, CSF-1, in placental development. Nature 330 (1987) 484-486
31. Khatami M. Standardizing cancer biomarkers criteria: data elements as a foundation for a database. Inflammatory mediator/M-CSF as model marker. Cell Biochem Biophys 47 (2007) 187-198
32. Groblewska M., Mroczko B., Wereszczynska-Siemiatkowska U., Mysliwiec P., Kedra B., and Szmitkowski M. Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients. Clin Chem Lab Med 45 (2007) 30-34
33. Mroczko B., Groblewska M., Wereszczynska-Siemiatkowska U., Okulczyk B., Kedra B., Laszewicz W., et al. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Clin Chim Acta 380 (2007) 208-212
34. Mroczko B., Szmitkowski M., and Okulczyk B. Granulocyte-colony stimulating factor (G-CSF) and macrophage colony stimulating factor (M-CSF) in colorectal cancer patients. Clin Chem Lab Med 40 (2002) 351-355
35. Scholl S.M., Pallud C., Beuvon F., Hacene K., Stanley E.R., Rohrschneider L., et al. Anti-colony stimulating factor-1 antibody staining in primary breast adenocarcinomas correlate with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst 86 (1994) 120
36. Tamimi R.M., Brugge J.S., Freedman M.L., Miron A., Iglehart J.D., Colditz G.A., and Hankinson S.E. Circulating colony stimulating factor-1 and breast cancer risk. Cancer Res 68 (2008) 18-21
37. Suzuki M., Kobayashi H., Ohwada M., Terao T., and Sato I. Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary. Gynecol Oncol 68 (1998) 35-37
38. Suzuki M., Tamura N., Kobayashi H., Ohwada M., Terao T., and Sato I. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary. Gynecol Oncol 77 (2000) 405-409
39. Le Meur Y., Leprivey-Lorgeot V., Mons S., Jose M., Dantal J., Lemauff B., et al. Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection. Nephrol Dial Transplant 19 (2004) 1862-1865
40. Shadle P.J., Aldwin L., Nitecki D.E., and Koths K. Human macrophage colony-stimulating factor heterogeneity results from alternative mRNA splicing, differential glycosylation, and proteolytic processing. J Cell Biochem 40 (1989) 91-107
41. Savarese D.M., Valinski H., Quesenberry P., and Savarese T. Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines. Prostate 34 (1998) 80-91
42. Ide H., Seligson D.B., Memarzadeh S., Xin L., Horvath S., Dubey P., et al. Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression. PNAS 99 (2002) 14404-14409
43. Paietta E., Racevskis J., Stanley E.R., Andreeff M., Papenhausen P., and Wiernik P.H. Expression of the macrophage growth factor, CSF-1 and its receptor c-fms by a Hodgkin's disease-derived cell line and its variants. Cancer Res 50 (1999) 2049-2055
44. Wu K.F., Rao Q., Zheng G.G., He Z.H., Ying H.G., Song Y.H., et al. Enhancement of J6-1 human leukemic cell proliferation by membrane-bound M-CSF through a cell-cell contact mechanism II. Role of an M-CSF receptor-like membrane protein. Leuk Res 22 (1998) 55-60
45. Kirma N., Hammes L.S., Liu Y.G., Nair H.B., Valente P.T., Kumar S., et al. Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression. Cancer Res 67 (2007) 1918-1926
46. Leiserowitz G.S., Harris S.A., Subramaniam M., Keeney G.L., Podratz K.C., and Spelsberg T.C. The proto-oncogene c-fms is overexpressed in endometrial cancer. Gynecol Oncol 49 (1993) 190-196
47. Takeda S., Soutter W.P., Dibb N.J., and White J.O. Biological activity of the receptor for macrophage colony-stimulating factor in the human endometrial cancer cell line, Ishikawa. Br J Cancer 73 (1996) 615-619
48. Smith H.O., Anderson P.S., Kuo D.Y., Goldberg G.L., DeVictoria C.L., Boocock C.A., et al. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. Clin Cancer Res 1 (1995) 313-325
49. Kacinski B.M., Scata K.A., Carter D., Yee L.D., and Sapi E. FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. Oncogene 6 (1991) 941-952
50. Kacinski B.M. CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. Mol Reprod Dev 46 (1997) 71-74
51. Tang R., Beuvon F., Ojeda M., Mosseri V., Pouillart P., and Scholl S. M-CSF and M-CSF receptor expression by breast tumor cells: M-CSF mediated recruitment of tumor infiltrating monocytes. J Cell Biochem 50 (1992) 350-356
52. Ramakrishnan F., Xu J., Brandt S.J., Niedel J.E., Bast R.C., and Brown E.L. Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J Clin Invest 83 (1989) 921-926
53. Biswas S.K., Sica A., and Lewis C.E. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol 180 (2008) 2011-2017
54. Jadus M.R., Terry Wepsic H., and Jeffes E.W.B. The biology and potential anti-cancer uses of the membrane form of macrophage colony stimulating factor. Recent Res Dev Immunol 1 (1999) 267-281
55. Ladner M.B., Martin G.A., Noble J.A., Nikoloff D.M., Tal R., Kawasaki E.S., et al. Human CSF-1: gene structure and alternative splicing of mRNA precursors. EMBO J 6 (1987) 2693-2698
56. Kawasaki E.S., Ladner M.B., Wang A.M., Van Arsdell J., Warren M.K., Coyne M.Y., et al. Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). Science 230 (1985) 291-296
57. Rajavashisth T.B., Eng R., Shadduck R.K., Waheed A., Ben-Avram C.M., Shively J.E., et al. Cloning and tissue-specific expression of mouse macrophage colony-stimulating factor mRNA. PNAS 84 (1987) 1157-1161
58. Ladner M.B., Martin G.A., Noble J.A., Wittman V.P., Warren M.K., McGrogan M., et al. cDNA cloning and expression of murine macrophage colony-stimulating factor from L929 cells. PNAS 85 (1988) 6706-6710
59. Wong G.G., Temple P.A., Leary A.C., Witek-Giannotti J.S., Yang Y.C., Ciarletta A.B., et al. Human CSF-1: molecular cloning and expression of the 4-kb cDNA encoding the human urinary protein. Science 235 (1987) 1504-1508
60. Cerreti D.P., Wignall J., and Anderson D. Human macrophage colony stimulating factor: alternative RNA and protein processing from a single gene. Mol Immunol 25 (1988) 761-770
61. Das S.K., and Stanley E.R. Structure-function studies of a colony stimulating factor (CSF-1). J Biol Chem 257 (1982) 13679-13684
62. Pandit J., Bohm A., Jancarik J., Halenbeck R., Koths K., and Kim S.H. Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor. Science 258 (1992) 1358-1362
63. Koths K. Structure-function studies on human macrophage colony-stimulating factor (M-CSF). Mol Reprod Dev (1997) 31-37
64. Taylor E.W., Fear A.L., Bohm A., Kim S.H., and Koths K. Structure-function studies on recombinant human macrophage colony-stimulating factor (M-CSF). J Biol Chem 269 (1994) 31171-31177
65. Ohtsuki T., Hatake K., Suzu S., Motoyoshi K., and Miura Y. Immunohistochemical identification of a proteoglycan form of macrophage colony stimulating factor on bone surface. Calcif Tissue Int 57 (1995) 213-217
66. Price L.K.H., Choi H.U., Rosenberg L., and Stanley E.R. The predominant form of the secreted colony stimulating factor-1 is a proteoglycan. J Biol Chem 267 (1992) 2190-2199
67. Suzu S., Kimura F., Yamada M., Yanai N., Kawashima T., Nagata N., et al. Direct interaction of proteoglycan macrophage colony-stimulating factor and basic fibroblast growth factor. Blood 83 (1994) 3113-3119
68. Suzu S., Kimura F., Matsumoto H., Yamada M., Hashimoto K., Shimamura S., et al. Identification of binding domains for basic fibroblast growth factor in proteoglycan macrophage colony-stimulating factor. Biochem Biophys Res Commun 230 (1997) 392-397
69. Chang M.Y., Olin K.L., Tsoi C., Wight T.N., and Chait A. Human monocyte-derived macrophages secrete two forms of proteoglycan-macrophage colony-stimulating factor that differ in their ability to bind low density lipoproteins. J Biol Chem 273 (1998) 15985-15992
70. Halenbeck R., Kawasaki E., Wrin J., and Koths K. Renaturation and purification of biologically active recombinant human macrophage colony-stimulating factor expressed in E. coli. BioTechnol 7 (1989) 710-715
71. Deng P., Wang Y.L., Shahbazian V.L., and Pattengale P.K. Biological characterization of uncleaveable plasma membrane-anchored human macrophage colony-stimulating factor. Biochem Biophys Res Commun 276 (2000) 304-311
72. Deng P., Wang Y.L., Haga Y., and Pattengale P.K. Multiple factors determine the selection of the ectodomain cleavage site of human cell surface macrophage colony-stimulating factor. Biochem 37 (1998) 17898-17904
73. Deng P., Wang Y.L., Pattengale P.K., and Rettenmier C.W. The role of individual cysteine residues in the processing, structure, and function of human macrophage colony-stimulating factor. Biochem Biophys Res Commun 228 (1996) 557-566
74. Deng P., Rettenmier C.W., and Pattengale P.K. Structural requirements for the ectodomain cleavage of human cell surface macrophage colony-stimulating factor. J Biol Chem 271 (1996) 16338-16343
75. J. Stein, C.W. Rettenmier, Proteolytic processing of a plasma membrane membrane-bound precursor to human macrophage colony-stimulating factor (CSF-1) is accelerated by phorbol ester. Oncogene 1991;6:601-5.
76. Horiuchi K., Miyamoto T., Takaishi H., Hakozaki A., Kosaki N., Miyauchi Y., et al. Cell surface colony-stimulating factor 1 can be cleaved by TNF-alpha converting enzyme or endocytosed in a clathrin-dependent manner. J Immunol 179 (2007) 6715-6724
77. Rovida E., Paccagnini A., Del Rosso M., Peschon J., and Dello Sbarba P. TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. J Immunol 166 (2001) 1583-1589
78. Rao Q., Zheng G.G., Li G., Lin Y.M., and Wu K.F. Membrane-bound macrophage colony-stimulating factor mediated auto-juxtacrine downregulates matrix metalloproteinase-9 release on J6-1 leukemic cell. Exp Biol Med 229 (2004) 946-953
79. Donner L., Fedele L.A., Garon C.F., Anderson S.J., and Sherr C.J. McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms). J Virol 41 (1982) 489-500
80. fms). Cell 39 (1984) 327-337
81. Coussens L., Van Beveren C., Smith D., Chen E., Mitchell R.L., Isacke C.M., et al. Structural alteration of vial homologue of receptor proto-oncogene fms at carboxyl terminus. Nature 320 (1986) 277-280
82. Roussel M.F., Dull T.J., Rettenmier C.W., Ralph P., Ullrich A., and Sherr C.J. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature 325 (1987) 549-552
83. Woolford J., McAuliffe A., and Rohrschneider L.R. Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype. Cell 55 (1988) 965-977
84. Roussel M.F., Downing J.R., Rettenmier C.W., and Sherr C.J. A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential. Cell 55 (1988) 979-988
85. Lo A.S., Taylor J.R., Farzaneh F., Kemeny D.M., Dibb N.J., and Maher J. Harnessing the tumour-derived cytokine, CSF-1, to co-stimulate T-cell growth and activation. Mol Immunol 45 (2008) 1276-1287
86. Strockbine L.D., Cohen J.I., Farrah T., Lyman S.D., Wagener F., DuBose R.F., et al. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J Virol 72 (1998) 4015-4021
87. Sheng W., Decaussin G., Sumner S., and Ooka T. N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is essential for malignant transformation of rodent fibroblasts and activation of BCL-2. Oncogene 20 (2001) 1176-1185
88. Horiuchi K., Miyamoto T., Takaishi H., Hakozaki A., Kosaki N., Miyauchi Y., et al. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J Med Virol 76 (2005) 82-88
89. Wei M.X., and Ooka T. A transforming function of the Barf-1 gene encoded by Epstein-Barr virus. EMBO J 10 (1989) 2897-2903
90. Sheng W., Decaussin G., Ligout A., Takada K., and Ooka T. Malignant transformation of the Epstein-Barr virus negative Akata cells by introduction of the Barf-1 gene carried by Epstein-Barr virus. J Virol 77 (2003) 3859-3865
91. Wei M.X., de Turenne-Tessier M., Decaussin G., Benet G., and Ooka T. Establishment of a monkey kidney epithelial cell line with the Barf-1 open reading frame from Epstein-Barr virus. Oncogene 14 (1997) 3073-3081
92. Stein J., Borzillo G.V., and Rettenmier C.W. Direct stimulation of cells expressing receptors for macrophage colony-stimulating factor (CSF-1) by plasma membrane-bound precursor of human CSF-1. Blood 76 (1990) 1308-1314
93. Uemura N., Ozawa K., Takahashi K., Tojo A., Tani K., Harigaya K., et al. Binding of membrane anchored macrophage colony stimulating factor (M-CSF) to its receptor mediates specific adhesion between stromal cells and M-CSF receptor bearing hematopoietic cells. Blood 82 (1993) 2634-2640
94. Li W., and Stanley E.R. Role of dimerization and modification of the CSF-1 receptor in its activation and internalization during the CSF-1 response. EMBO J 10 (1991) 277-288
95. Shurtleff S.A., Downing J.R., Rock C.O., Hawkins S.A., Roussel M.F., and Sherr C.J. Structural features of the colony-stimulating factor 1 receptor that affects its association with phosphatidylinositol-3 kinase. EMBO J 9 (1990) 2415-2421
96. Varticovski L., Druker B., Morrison D., Cantley L., and Roberts T. The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase. Nature 342 (1989) 699-702
97. Reedijik M., Liu X., van der Geer P., Waterfield M.D., Hunter T., and Pawson T. Tyr 721 regulates specific binding of the CSF-1 receptor kinase insert to PI-3 kinase SH2 domains: a model for SH2 mediated receptor-target interaction. EMBO J 11 (1992) 1365-1372
98. Novak U., Harpur A.G., Paradiso L., Kanagasundaram V., Jaworowski A., Wilks A.F., et al. Colony stimulating factor-1 induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts. Blood 86 (1995) 2948-2956
99. Buscher D., Hipskind R.A., Krautwald S., Reiman T., and Baccarini M. Ras-dependent and independent pathways target the mitogen-activated protein kinase network in macrophages. Mol Cell Biol 15 (1994) 466-474
100. Baccarini M., Sabatini D.M., App H., Rapp U.R., and Stanley E.R. Colony stimulating factor-1 stimulates temperature dependent phosphorylation and activation of the raf-1 proto-oncogene product. EMBO J 9 (1990) 3649-3657
101. Xu X.X., Rock C.O., Qui Z.H., Leslie C.C., and Jackowski S. Regulation of cytosolic phospholipase A2 and eicosanoid production by colony stimulating factor 1. J Biol Chem 269 (1994) 31693-31700
102. Yeung Y.G., Berg K.L., Pixley F.J., Angeletti R.H., and Stanley E.R. Protein tyrosine phosphatase-1C is rapidly phosphorylated on tyrosine in macrophages in response to colony stimulating factor-1. J Biol Chem 267 (1992) 23447-23450
103. Junttila I., Bourette R.P., Rohrschneider L.R., and Silvennoinen O. M-CSF induced differentiation of myeloid precursor cells involves activation of PKC-delta and expression of Pkare. J Leukoc Biol 73 (2003) 281-288
104. Xu X.X., Tessner T.G., Rock C.O., and Jackowski S. Phosphatidylcholine hydrolysis and c-myc expression are in collaborating mitogenic pathways activated by colony stimulating factor-1. Mol Cell Biol 13 (1993) 1522-1530
105. Bourette R.P., Arnaud S., Myles G.M., Blanchet J.P., Rohrschneider L.R., and Mouchiroud G. Mona, a novel hematopoietic-specific adaptor interacting with the macrophage colony-stimulating factor receptor, is implicated in monocyte/macrophage development. EMBO J 17 (1998) 7273-7281
106. Tushinski R.J., and Stanley E.R. The regulation of mononuclear phagocyte entry into S phase by the colony stimulating factor CSF-1. J Cell Physiol 122 (1985) 221-228
107. Lee P.S., Wang Y., Dominguez M.G., Yeung Y.G., Murphy M.A., Bowtell D.D., et al. The Cbl proto-oncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation. EMBO J 18 (1999) 3616-3628
108. Carlberg K., Tapley P., Haystead C., and Rohrschneider L. The role of kinase activity and the kinase insert region in ligand-induced internalization and degradation of the c-fms protein. EMBO J 10 (1991) 877-883
109. Mancini A., Koch A., Wilms R., and Tamura T. c-Cbl associates directly with the C-terminal tail of the receptor for the macrophage colony-stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms. J Biol Chem 277 (2002) 14635-14640
110. Yoshida H., Hayashi S., Kunisada T., Ogawa M., Nishikawa S., Okamura H., et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345 (1990) 442-444
111. Wiktor-Jedrzejczak W., Bartocci A., Ferrante Jr. A.W., Ahmed-Ansari A., Sell K.W., Pollard J.W., et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. PNAS 87 (1990) 4828-4832
112. Dai X.M., Ryan G.R., Hapel A.J., Dominguez M.G., Russell R.G., Kapp S., et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99 (2002) 111-120
113. Yao G.Q., Wu J.J., Sun B.H., Troiano N., Mitnick M.A., and Insogna K. The cell surface form of colony-stimulating factor-1 is biologically active in bone in vivo. Endocrinol 144 (2003) 3677-3682
114. Biskobing D.M., Fan X., and Rubin J. Characterization of M-CSF-induced proliferation and subsequent osteoclast formation in murine marrow culture. J Bone Miner Res 10 (1995) 1025-1032
115. Ryan G.R., Dai X.M., Dominguez M.G., Tong W., Chuan F., Chisholm O., et al. Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 98 (2001) 74-84
116. Ovadia S., Insogna K., and Yao G.Q. The cell-surface isoform of colony stimulating factor 1 (CSF1) restores but does not completely normalize fecundity in CSF1-deficient mice. Biol Reprod 74 (2006) 331-336
117. Teitelbaum S.L. Osteoclasts: culprits in inflammatory osteolysis. Arthritis Res Ther 8 (2006) 201-209
118. Zaidi M. Skeletal remodeling in health and disease. Nat Med 13 (2007) 791-801
119. 3 and macrophage colony-stimulating factor: partners in osteoclast biology. Immunol Rev 208 (2005) 88-105
120. Takemura R., Stenberg P.E., Bainton D.F., and Werb Z. Rapid redistribution of clathrin onto macrophage plasma membranes in response to Fc receptor-ligand interaction during frustrated phagocytosis. J Cell Biol 102 (1986) 55-69
121. Yao G.Q., Sun B.H., Hammond E.E., Spencer E.N., Horowitz M.C., Insogna K.L., et al. The cell form of colony-stimulating factor-1 is regulated by osteotropic agents and supports formation of multinucleated osteoclast-like cells. J Biol Chem 273 (1998) 4119-4128
122. Rubin J., Biskobing D.M., Jadhav L., Fan D., Nanes M.S., Perkins S., et al. Dexamethasone promotes expression of membrane-bound macrophage colony-stimulating factor in murine osteoblast-like cells. Endocrinology 139 (1998) 1006-1012
123. Rubin J., Fan D., Wade A., Murphy T.C., Gewant H., Nanes M.S., et al. Transcriptional regulation of the expression of macrophage colony stimulating factor. Mol Cell Endocrinol 160 (2000) 193-202
124. Dan Q., Trinh H., Williams C.C., Lloyd C., Wepsic H.T., Jeffes E.W.B., and Jadus M.R. Dexamethasone increases the expression of membrane macrophage colony stimulating factor expressing this novel membrane cytokine. Int Immunopharmacol 1 (2001) 737-748
125. Dean T., Vilardaga J.P., Potts Jr. J.T., and Gardella T.J. Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor. Mol Endocrinol 22 (2008) 156-166
126. Silve C.M., Hradek G.T., Jones A.L., and Arnaud C.D. Parathyroid hormone receptor in intact embryonic chicken bone: characterization and cellular localization. J Cell Biol 94 (1982) 379-386
127. Deftos L.J. Hypercalcemia in malignant and inflammatory diseases. Endocrinol Metab Clin N Am 31 (2002) 141-158
128. Ramsay R.G., Micallef S.J., Williams B., Lightowler S., Vincan E., Heath J.K., et al. Colony stimulating factor-1 promotes clonogenic growth of normal murine colonic crypt epithelial cells in vitro. J Interferon Cytokine Res 24 (2004) 416-427
129. Zapata-Velandia A., Ng S.S., Brennan R.F., Simonsen N.R., Gastanaduy M., Zabaleta J., et al. Association of the T allele of an intronic single nucleotide polymorphism in the colony stimulating factor-1 receptor with Crohn's disease: a case control study. J Immunol Based Therap Vaccines 2 (2004) 6-14
130. Leung E., Hong J., Fraser A.G., Merriman T.R., Vishnu P., and Krissansen G.W. Colony-stimulating factor-1 receptor gene polymorphisms and Crohn's disease. Int J Colorectal Dis 22 (2007) 995-996
131. Makiyama K., Tomonaga M., Nakamuta K., Oda H., Itsuno M., and Hara K. Serum concentration of macrophage colony stimulating factor (M-CSF) in patients with inflammatory bowel disease. Gastroenterol Jpn 28 (1993) 740
132. Klebl F.H., Olsen J.E., Jain S., and Doe W.F. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine. J Pathol 195 (2001) 609-615
133. Marshall D., Cameron J., Lightwood D., and Lawson A.D. Blockade of colony stimulating factor-1 (CSF-1) leads to inhibition of DSS-induced colitis. Inflamm Bowel Dis 13 (2007) 219-224
134. Barton B.E. NBxFO factor-a novel suppressor factor produced by fusion of neonatal spleen and a non-secreting myeloma. Cell Immunol 115 (1988) 228-245
135. Jadus M.R., Irwin M.R., Barton B.E., Irwin M.N., and Wepsic H.T. The identification of the neonatal NBXFO hybridoma cell and its mediator. Comp Dev Immunol 19 (1995) 261-277
136. Serafini P., Borrello I., and Bronte V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 16 (2006) 53-65
137. Rabinovich G.A., Gabrilovich D., and Sotomayor E.M. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 25 (2007) 267-296
138. Nikcevich D.A., Duffie G.P., Young M.R., Ellis N.K., Kaufman G.E., and Wepsic H.T. Stimulation of suppressor cells in the bone marrow and spleens of high dose cyclophosphamide-treated C57Bl/6 mice. Cell Immunol 109 (1987) 349-359
139. Young M.R., Ellis N.K., Young M.E., and Wepsic H.T. Stimulation of hematopoiesis and bone marrow suppressor cells by the subcutaneous injection of linoleic acid. Cell Immunol 107 (1987) 238-248
140. Young M.R., Newby M., and Wepsic H.T. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res 47 (1987) 100-105
141. Jadus M.R., Irwin M.C.N., Irwin M.R., Horansky R.N., Sehkon S., Pepper S., et al. Macrophages can recognize and kill tumor cells bearing the membrane isoform of macrophage colony stimulating factor. Blood 87 (1996) 5232-5241
142. Jadus M.R., Chen Y., Boldaji M.T., Delgado C., Sanchez R., Douglass T., et al. Human U251MG glioma cells expressing the membrane form of macrophage colony-stimulating factor (mM-CSF) are killed by human monocytes in vitro and are rejected within immunodeficient mice via paraptosis that is associated with increased expression of three different heat shock proteins. Cancer Gene Ther 10 (2003) 411-420
143. Dan Q., Sanchez R., Delgado C., Wepsic H.T., Morgan K., Chen Y., et al. Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8 T cell immunity against the parental tumor. Mol Ther 4 (2001) 427-437
144. Graf M., Jadus M.R., Wepsic H.T., Hiserodt J.C., and Granger G.A. Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane bound isoform of macrophage colony stimulating factor (CSF-1). J Immunol 163 (1999) 5544-5551
145. Jadus M.R., Williams C.C., Avina M.D., Ly M., Kim S., Liu Y., et al. Macrophages kill T9 glioma tumor cells bearing the membrane isoform of macrophage colony stimulating factor through a phagocytosis-dependent pathway. J Immunol 160 (1998) 361-368
146. Chen Y., Douglass T., Jeffes E.W.B., Xu Q., Williams C., Arpajirakul N., et al. T9 glioma cancer cells expressing membrane macrophage colony stimulating factor leads to immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9 gliomas. Blood 100 (2002) 1373-1380
147. Williams C.C., Trinh H., Tran T.V., Dan Q., Sanchez R., Delgado C., et al. Membrane expression of macrophage colony stimulating factor on MADB106 breast cancer cells are not directly killed by macrophages in vitro, but lead to tumor rejection in vivo and immunizes against MADB106 parental cells. Mol Ther 3 (2001) 216-224
148. Sasmono R.T., Ehrnsperger A., Cronau S.L., Ravasi T., Kandane R., Hickey M.J., et al. Mouse neutrophilic granulocytes express mRNA encoding the macrophage colony-stimulating factor receptor (CSF-1R) as well as many other macrophage-specific transcripts and can trans-differentiate into macrophages in vitro in response to CSF-1. J Leukoc Biol 82 (2007) 111-123
149. Hoa N., Zhang J.G., Delgado C., Myers M.P., Callahan L.L., Vandeusen G., et al. BK channel activation results in paraptosis: a possible mechanism to explain monocyte-mediated killing of tumor cells expressing membrane macrophage colony stimulating factor. Lab Invest 87 (2007) 115-129
150. Delgado C., Jahroudi R.A., Zhang J.G., Hoa N., Schiltz P.M., Jadus M.R., et al. Generation of human immune responses towards a living U251MG glioma vaccine within SCID/beige mice. Cytokine 38 (2007) 165-176
151. Hoa N, Myers MP, Zhang JG, Delgado C, Callahan LL, Vandeusen G, et al. Molecular mechanisms of paraptosis induction: implications for a non-genetic modified tumor vaccine. (submitted for publication).
152. Sperandio S., de Belle I., and Bredesen D.E. An alternative, non-apoptotic form of programmed cell death. PNAS 97 (2000) 14376-14381
153. Bredesen D.E., Rao R.V., and Mehlen P. Cell death in the nervous system. Nature 443 (2006) 796-802
154. Schiltz P.M., Lee G.J., Hoa N., Wepsic H.T., Dillman R.O., and Jadus M.R. Human tumor cells are susceptible to cytolysis by allogeneic and xenogeneic cells via distinct pathways. Cancer biotherapy and radiopharmaceuticals. Cancer Biother Radiopharm 22 (2007) 672-683
155. Williams S.E., Wootton P., Mason H.S., Bould J., Iles D.E., Riccardi D., et al. Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 306 (2004) 2093-2097
156. Cassel D., Katz M., and Rotman M. Depletion of cellular ATP inhibits Na+/H+ antiport in cultured rat cells. J Biol Chem 261 (1986) 5460-5466
157. +-exchanger leads to caspase-independent death of cerebellar granule neurons resembling paraptosis. Cell Death Differ 11 (2004) 760-770
158. Yang H., Wang H., Czura C.J., and Tracey K.J. The cytokine activity of HGMB1. J Leukoc Biol 78 (2005) 1-8
159. Melcher A., Todryk S., Hardwick N., Ford M., Jacobson M., and Vile R.G. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med 4 (1998) 581-587
160. Gallucci S., Lolkema M., and Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 5 (1999) 1249-1255
161. Gallucci S., and Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 13 (2001) 114-119
162. Sha Y., Zmijewski, Xu Z., and Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol (2008) 2531-2537
163. Basu S., Binder R.J., Suto R., Anderson K.M., and Srivastava P.K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate NF-κB pathway. Int Immunol 12 (2000) 1539-1546
164. Basu S., Binder R.J., Ramalingam T., and Srivastava P.K. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70 and calreticulin. Immunity 14 (2001) 303-313
165. Kuppner M.C., Gastpar R., Gelwar S., Nossner E., Ochmann O., Scharner A., et al. The role of heat shock protein (HSP70) in dendritic cell maturation: Hsp70 induces the maturation of immature dendritic cells but reduce DC differentiation from monocyte precursors. Eur J Immunol 31 (2001) 1602-1609
166. Asea A., Kraeft S.K., Kurt-Jones E.A., Stevenson M.A., Chen L.B., Finberg R.W., et al. HSP70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6 (2000) 435-442
167. Chen K., Huang J., Gong W., Iribarren P., Dunlop N.M., and Wang J.M. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol 7 (2007) 1271-1285
168. Gabai V.L., and Kabakov A.E. Induction of heat-shock protein synthesis and thermotolerance in EL-4 ascites tumor cells by transient ATP depletion after ischemic stress. Exp Mol Pathol 60 (1994) 88-99
169. Kabakov A.E., Budagova K.R., Latchman D.S., and Kampinga H.H. Stressful preconditioning and HSP70 over expression attenuate proteotoxicity of cellular ATP depletion. Am J Physiol 283 (2002) C521-534
170. Chiang C.C., Ledermann J.A., Rad A.N., Katz D.R., and Chain B.M. Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells. Cancer Immunol Immunother 55 (2006) 1384-1395
171. Rutault K., Alderman C., Chain B.M., and Katz DR. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic Biol Med 26 (1999) 232-238
172. Eguchi Y., Shimuzu S., and Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 57 (1997) 1835-1840
173. Nicotera P., Leist M., Fava E., Berliocchi L., and Volbracht L. Energy requirement for caspase activation and neuronal cell death. Brain Pathol 10 (2000) 276-282
174. Leist M., Single B., Castoldi A.F., Kuhnle S., and Nicotera P. Intracellular adenosine tri-phosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 185 (1997) 1481-1486
175. Barker R.N., Erwig L., Pearce W.P., Devine A., and Rees A.J. Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages. Pathobiology 67 (1999) 302-305
176. Voll R.E., Herrmann M., Roth E.A., Stach C., and Kalden J.R. Immunosuppressive effects of apoptotic cells. Nature 390 (1997) 350-351
177. Steinman R.M., Turley S., Mellman I., and Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 191 (2000) 411-416
178. Sauter B., Albert M.L., Francisco L., Larsson M., Somersan S., and Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 191 (2000) 423-433
179. Fadok V.A., Bratton D.L., Konowaal A., Freed P.W., Westcott J.Y., and Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit pro-inflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-ß, PGE2 and PAF. J Clin Invest 101 (1998) 890-898
180. Reiter I., Krammer B., and Schwamberger G. Differential effect of apoptotic versus necrotic tumor cells on macrophage anti-tumor activities. J Immunol 163 (1999) 1730-1732
181. Rock K.L., and Kono H. The inflammatory response of cell death. Ann Rev Pathol Mech Dis 3 (2008) 99-126
182. Probst-Kepper M., Stroobant V., Kridel R., Gaugler B., Landry C., Brasseur F., et al. An alternative open reading frame of the human macrophage colony stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor infiltrating CD8 T lymphocytes. J Exp Med 193 (2001) 1189-1198
183. Shami K., Tirosh B., Bar-Haim E., Carmon L., Vadai E., Fridkin M., et al. MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope. Eur J Immunol 29 (1999) 3295-3301
184. Markiewicz M.A., Fallarino F., Ashikari A., and Gajewski T.F. Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A. Int Immunol 13 (2001) 625-632
185. Sanchez R., Williams C., Daza J.L., Dan Q., Xu Q., Chen Y., et al. T9 glioma cells expressing membrane macrophage colony stimulating factor produce CD4 + associated protective immunity against T9 intracranial gliomas and systemic immunity against different syngeneic glioma cells. Cell Immunol 216 (2002) 1-11
186. Okada H., Giezeman-Smits K.M., Tahara H., Attanucci J., Fellows W.K., Lotze M.T., et al. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine. Gene Ther 6 (1996) 219-226
187. Folkman J. Looking for a good endothelial address. Cancer Cell 1 (2002) 113-117
188. Boehm T., Folkman J., Browder T., and O'Reilly M.S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390 (1997) 404-407
189. Jeffes E.W.B., Zhang J.G., Hoa N., Pektar A., Delgado C., Chong S., et al. Anti-angiogenic drugs synergize with a membrane macrophage colony stimulating factor based tumor vaccine to therapeutically treat rats with an established intracranial malignant glioma. J Immunol 174 (2005) 2533-2543
190. Garcia E., Garcia G., De la Puerta R., Espartero J.L., and Saenz M.T. Antiproliferative effects of mitraphylline, a pentacyclic oxindole alkaloid of Uncaria tomentosa on human glioma and neuroblastoma cell lines. Phytomedicine 14 (2007) 280-284
191. Gonzales G.F., and Valerio Jr. L.G. Medicinal plants from Peru: a review of plants as potential agents against cancer. Curr Med Chem Anti-Canc Agents 6 (2006) 429-444
192. Montoro P., Carbone V., Quiroz Jde D., De Simone F., and Pizza C. Identification and quantification of components in extracts of Uncaria tomentosa by HPLC-ES/MS. Phytochem Anal 15 (2004) 55-64
193. Riva L., Coradini D., Di Fronzo G., De Feo V., De Tommasi N., De Simone F., et al. The antiproliferative effects of Uncaria tomentosa extracts and fractions on the growth of breast cancer cell line. Anticancer Res 21 (2001) 2457-2461
194. Sheng Y., Bryngelsson C., and Pero R.W. Enhanced DNA repair, immune function and reduced toxicity of C-MED-100, a novel aqueous extract from Uncaria tomentosa. J Ethnopharmacol 69 (2000) 115-126
195. Gee M.S., Makonnen S., Kofahi K., Roysam B., Payvandi F., Man H.W., et al. Selective cytokine inhibitory drugs with enhanced antiangiogenic activity control tumor growth through vascular inhibition. Cancer Res 63 (2003) 8073-8078
196. Dredge K., Marriott J.B., Macdonald C.D., Man H.W., Chen R., Muller G.W., et al. Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. Br J Cancer 87 (2002) 1166-1172
197. Masuda M., Suzui M., Lim J.T., Deguchi A., Soh J.W., and Weinstein I.B. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol 2 (2002) 350-359
198. Jung Y.D., Kim M.S., Shin B.A., Chay K.O., Ahn B.W., Liu W., et al. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer 84 (2001) 844-850
199. Ahn S.C., Kim G.Y., Kim J.H., Baik S.W., Han M.K., Lee H.J., et al. Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappa B. Biochem Biophys Res Commun 313 (2004) 148-155
200. Jain R.K., and Carmeliot P. Vessels of life or death. Sci Am 285 (2001) 38-45